Fineotex Chemical Ltd ( My Observation ,no recommendations )
Market Cap 1,232 Cr.
Current Price 111
High / Low 120 / 29.2
Book Value 18.9
Promotors holding-around 65% ( In Last 3 yrs from 72.36 to 64.72 and last few month 64.72 to 64.82)

-OPM betwee 18-19% ( consolidated )in last 3-4 yrs
standalone between 20-25%
-sales growth last 3 yrs 16% and profit growth 23%
- Almost debt free
- High debtor days
-Good ROCE and ROE
EBITDA Margins - Company is hopeful for maintaining margins of 18-19%
-Manufacturing ,JV and R&D
1- Navi Mumbai- Capacity 36000 MT
2 Malaysia -6500 MT
3- Upcoming- Ambernath facility - 36000 TPA
4-JV with HealthGuard Australia for durable metal-free sustainable chemistry solutions that are anti-microbial and anti-viral(textile,detergent, leather and allied products)
5-Sasmira-Setting up a state of art Research & Development centre in collaboration with Sasmira Institute, one of India’s premier textile institutes
-Fy 21 R&D expenses 1.85 cr with top line of 219 cr ( I hope after Sasmira Tie up R&D will be much better
The capacities for the company are fungible across segments and products. This has resulted in better revenue generation on every unit of investment. Additionally, the investment required to put up additional capacities is low for the company and this has supported the strong
RoCE at 21-22% and asset turnover of more than 5 times over the past few years
Business Segment -
- Textile ( Major Revenue)
- Home Care and Hygiene( Recent Entry )
- Drilling ( Recent entry)
-Other Specialities
-Speciality textiles - FCL manufactures chemicals for entire valve chain in textile segment from weaving to finishing.
- Major Customer ( See Below)
Sales in 60+ countries including Brazil, Bangladesh, Germany, Indonesia, Malaysia, Singapore, Syria, Thailand, USA, Venezuela and Vietnam
-Revenue mix ( FY 21) 57% international 43% india
Aquastrike VCF–( Product developed by Malaysian subsidiary ) waiting for WHO Approval since last 3 yrs ( Not sure whether they will get approval or not but its a interesting product )
It is a non toxic, non polluting, Eco-friendly solution, produced
• Simply poured on the water surface at a rate of 1ml per square meter, the silicon based
liquid forms a molecule thick film, that doesn't stop water oxygenation (so no effect on fish, worms, snails and vegetals) but alter the water surface tension
. As a result, larvae and pupae are unable to attach their breathing syphon and end up drowning.
• The adult mosquitoes while trying to lay eggs on the surface of the water, drown because of the lower surface tension.
• It doesn't kill the mosquitoes by poisoning. Aquastrike effect is physical not chemical,
which eliminates the risk of mosquito developing immunity to the product as it is the case
with some insecticides or even BTI.
Risk -
1- Big European competitors
Clariant ( Archroma)
Huntsman
Woodolf
CHT
Woolera
ICI Croda
2-Sebi Fined Promotors for IPO case
3- Many family transections ( Probably to save Tax) Read article by Dr Vijay Malik for Details .
Why I bought shares of FCL
1- New capacity in coming up
2- Tie Up with Health Guard Australia for products
3- Growth in Textile industry
4- Recent entry in Home care and Hygiene Products
5- R&D will be better with SASMIRA tie-up.

More from drprashantmishra

GSFC Some Facts -
1- Its a Government company with mcap of around 5000cr
2-Its having Debt of only 35 Cr with Deposit of 1000 Cr
3-Its investment value
GNFC -almost 3 cr shares X437=1300 cr
Guj Ind power 2.23crX 85=189 Cr
GACL 16 lacX = 107 cr

Guj
https://t.co/v6Yk7U34AA corp 9 lacX6.8=63 lac
Gujarat Gas 4.7 CrX=2968 cr
Bandhan Bank 11.35X284 =32 cr
IDBI 5.5 lacX 44= 2.4 cr
MCFL 5.8 lac X 76= 4.4 cr
Total value of investment =4700 Cr

Production capacity of Its plant for Various products + Methanol plant plus Melamine plants


Major Raw Material
Rock phosphate
Ammonia
Benzene
Phosphoric acid
sulfur

Expansion-
1-ammonium sulphate 4th plant of 400 metric tonnes capacity - Revenue estimated 230 Cr
2- sulphuric acid, fifth plant. 600 metric tonnes per day for captive consumption.

You May Also Like

I just finished Eric Adler's The Battle of the Classics, and wanted to say something about Joel Christiansen's review linked below. I am not sure what motivates the review (I speculate a bit below), but it gives a very misleading impression of the book. 1/x


The meat of the criticism is that the history Adler gives is insufficiently critical. Adler describes a few figures who had a great influence on how the modern US university was formed. It's certainly critical: it focuses on the social Darwinism of these figures. 2/x

Other insinuations and suggestions in the review seem wildly off the mark, distorted, or inappropriate-- for example, that the book is clickbaity (it is scholarly) or conservative (hardly) or connected to the events at the Capitol (give me a break). 3/x

The core question: in what sense is classics inherently racist? Classics is old. On Adler's account, it begins in ancient Rome and is revived in the Renaissance. Slavery (Christiansen's primary concern) is also very old. Let's say classics is an education for slaveowners. 4/x

It's worth remembering that literacy itself is elite throughout most of this history. Literacy is, then, also the education of slaveowners. We can honor oral and musical traditions without denying that literacy is, generally, good. 5/x
"I lied about my basic beliefs in order to keep a prestigious job. Now that it will be zero-cost to me, I have a few things to say."


We know that elite institutions like the one Flier was in (partial) charge of rely on irrelevant status markers like private school education, whiteness, legacy, and ability to charm an old white guy at an interview.

Harvard's discriminatory policies are becoming increasingly well known, across the political spectrum (see, e.g., the recent lawsuit on discrimination against East Asian applications.)

It's refreshing to hear a senior administrator admits to personally opposing policies that attempt to remedy these basic flaws. These are flaws that harm his institution's ability to do cutting-edge research and to serve the public.

Harvard is being eclipsed by institutions that have different ideas about how to run a 21st Century institution. Stanford, for one; the UC system; the "public Ivys".
"I really want to break into Product Management"

make products.

"If only someone would tell me how I can get a startup to notice me."

Make Products.

"I guess it's impossible and I'll never break into the industry."

MAKE PRODUCTS.

Courtesy of @edbrisson's wonderful thread on breaking into comics –
https://t.co/TgNblNSCBj – here is why the same applies to Product Management, too.


There is no better way of learning the craft of product, or proving your potential to employers, than just doing it.

You do not need anybody's permission. We don't have diplomas, nor doctorates. We can barely agree on a single standard of what a Product Manager is supposed to do.

But – there is at least one blindingly obvious industry consensus – a Product Manager makes Products.

And they don't need to be kept at the exact right temperature, given endless resource, or carefully protected in order to do this.

They find their own way.